Article

French Biomarker Company TcLand Names Huriez Chairman and CEO

TcLand S.A. (Nantes, France, www.tcland-biotech.com) has named Alain Huriez, MD, one of the company's co-founders, as Chairman and CEO.

TcLand S.A. (Nantes, France, www.tcland-biotech.com) has named Alain Huriez, MD, one of the company’s co-founders, as Chairman and CEO. Past roles held by Huriez include vice president of Quintiles Europe (in charge of the firm’s biotechnology consulting group) and CEO of Neovacs SA. TcLand developed diagnostic biomarkers and therapeutic molecules for patients with immune disorders, and runs immunological tests for biopharmaceutical companies conducting clinical trials.

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Related Videos
How the 15% US-EU Tariff Cap Affects Bio/pharma
Dave Miller, PhD, Chief Scientific Officer, AustinPx
Dave Miller, PhD, Chief Scientific Officer, AustinPx
© 2025 MJH Life Sciences

All rights reserved.